- Home
- TPST vs GRF Comparison
TPST vs GRF Comparison
Compare TPST & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- GRF
- Stock Information
- Founded
- TPST 2011
- GRF 1989
- Country
- TPST United States
- GRF United States
- Employees
- TPST N/A
- GRF N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- GRF Finance/Investors Services
- Sector
- TPST Health Care
- GRF Finance
- Exchange
- TPST Nasdaq
- GRF Nasdaq
- Market Cap
- TPST 33.0M
- GRF 39.3M
- IPO Year
- TPST N/A
- GRF N/A
- Fundamental
- Price
- TPST $7.76
- GRF $10.26
- Analyst Decision
- TPST Hold
- GRF
- Analyst Count
- TPST 3
- GRF 0
- Target Price
- TPST $30.00
- GRF N/A
- AVG Volume (30 Days)
- TPST 80.4K
- GRF 3.0K
- Earning Date
- TPST 08-07-2025
- GRF 01-01-0001
- Dividend Yield
- TPST N/A
- GRF 3.70%
- EPS Growth
- TPST N/A
- GRF N/A
- EPS
- TPST N/A
- GRF 1.16
- Revenue
- TPST N/A
- GRF N/A
- Revenue This Year
- TPST N/A
- GRF N/A
- Revenue Next Year
- TPST N/A
- GRF N/A
- P/E Ratio
- TPST N/A
- GRF $8.15
- Revenue Growth
- TPST N/A
- GRF N/A
- 52 Week Low
- TPST $5.35
- GRF $7.93
- 52 Week High
- TPST $28.34
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- TPST 63.65
- GRF 60.46
- Support Level
- TPST $6.11
- GRF $9.86
- Resistance Level
- TPST $6.49
- GRF $10.94
- Average True Range (ATR)
- TPST 0.35
- GRF 0.12
- MACD
- TPST 0.03
- GRF 0.04
- Stochastic Oscillator
- TPST 100.00
- GRF 37.61
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.